# reload+after+2024-01-21 20:21:44.637086
address1§The CTF Building
address2§48 Grafton Street
city§Manchester
zip§M13 9XX
country§United Kingdom
phone§44 16 1989 0245
website§https://www.genedriveplc.com
industry§Diagnostics & Research
industryKey§diagnostics-research
industryDisp§Diagnostics & Research
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
fullTimeEmployees§43
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Russell John Shaw', 'age': 45, 'title': 'CFO, Secretary & Director', 'yearBorn': 1978, 'fiscalYear': 2023, 'totalPay': 158077, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. James  Cheek', 'title': 'CEO & Director', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Gino  Miele', 'title': 'Chief Scientific Officer & Executive Director', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.225
priceToSalesTrailing12Months§180.87747
currency§GBp
forwardEps§2.1
exchange§LSE
quoteType§EQUITY
shortName§GENEDRIVE PLC ORD 1.5P
longName§genedrive plc
firstTradeDateEpochUtc§1175670000
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§0fb51ae9-2143-38ab-83f8-22b443576b0e
messageBoardId§finmb_28092833
recommendationKey§none
quickRatio§1.423
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
